# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-005395
Filing Date
2015-11-13
Accepted
2015-11-13 07:04:00
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm | 10-Q | 878383
2 |  | ex31-1.htm | EX-31.1 | 20539
3 |  | ex31-2.htm | EX-31.2 | 20210
4 |  | ex32-1.htm | EX-32.1 | 7897
5 |  | ex32-2.htm | EX-32.2 | 7795
| Complete submission text file | 0001493152-15-005395.txt |  | 4514688

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE FILE | aker-20150930.xml | EX-101.INS | 701293
7 | XBRL SCHEMA FILE | aker-20150930.xsd | EX-101.SCH | 59322
8 | XBRL CALCULATION FILE | aker-20150930_cal.xml | EX-101.CAL | 70056
9 | XBRL DEFINITION FILE | aker-20150930_def.xml | EX-101.DEF | 173170
10 | XBRL LABEL FILE | aker-20150930_lab.xml | EX-101.LAB | 423939
11 | XBRL PRESENTATION FILE | aker-20150930_pre.xml | EX-101.PRE | 291638

Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 151226888
SIC: 2835 In Vitro & In Vivo Diagnostic Substances